about
TNF-alpha inhibitors for psoriatic arthritisTreatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients.Dactylitis in psoriatic arthritis: a marker for disease severity?Psoriatic arthritis clinical registries and genomics.Predictors for radiological damage in psoriatic arthritis: results from a single centre.Psoriatic arthritis imaging: a review of scoring methods.Characterization of new bone formation in gout: a quantitative site-by-site analysis using plain radiography and computed tomographyObservational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program.Imaging in psoriatic arthritis.Arthritis mutilans.EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice.A two-phase model for chronic disease processes under intermittent inspection.The association between sonographic enthesitis and radiographic damage in psoriatic arthritis.Clinical and radiological damage in psoriatic arthritis.Deoxyribonuclease activity of polyclonal IgGs: a putative serological marker in patients with spondyloarthritides.The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year.Composite likelihood for joint analysis of multiple multistate processes via copulas.Incidence of arthritis in a prospective cohort of psoriasis patients.Penalized regression for interval-censored times of disease progression: Selection of HLA markers in psoriatic arthritis.Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis.Clinical Enthesitis in a Prospective Longitudinal Psoriatic Arthritis Cohort: Incidence, Prevalence, Characteristics, and Outcome.Feasibility, reliability, and sensitivity to change of four radiographic scoring methods in patients with psoriatic arthritis.[Imaging methods in rheumatology: imaging in psoriasis arthritis (PsA)].Minimal disease activity and anti-tumor necrosis factor therapy in psoriatic arthritis.
P2860
Q24240905-72E5F403-C0B9-4084-9636-06890FC0E433Q33358541-68DFDE3F-8312-463C-96DF-C337A0EF2659Q35555241-EDE10BD2-C01F-4524-9A21-5FDEF4569E9BQ35579414-0AF5B549-2CB6-419A-A636-F8F7BB8A0998Q35760034-ABB4B1A8-2127-4E07-9585-139A99FCB1B8Q36040076-2FA763A7-B865-4521-AC61-32075C5CC9AEQ36633315-782605AE-97EC-44B5-B286-B6F4066310D9Q37778661-55632DD3-A767-4207-BD97-3CA53EE1CADDQ37980390-3DB8DF8C-709E-47FD-A649-B3229700553DQ38083619-7BE2E845-AE82-470D-9336-1E2386C4839AQ38402703-8C57E571-22AC-4716-BBB0-BA770C7B8DE9Q38941654-EA374873-88B5-4A60-9D94-8E743AF3269EQ41431785-2A06E377-5A15-4A49-86E3-0AB66603E0B7Q42174115-82EE05A0-8E66-42DC-8F8C-3AF34818F7EAQ42266445-C555B736-2BFD-4885-BEAF-F1F589255917Q42955715-8279BC0F-EB47-4B7D-B90E-AB23248920FAQ43707125-86E3B776-A73B-40BC-BF72-7F9E4FE29B20Q44085566-B91038EB-7E73-4E8D-91F0-B93BE7D3285DQ47667962-304E9094-F3DD-495C-A746-B67EB10894E6Q51040429-125C07E6-6E0C-415C-9195-9EF923FB2D72Q51327638-D18B2DD1-0A30-4E0E-89EA-42F172105088Q53124125-7FAB45DB-F5AF-4A64-A3AA-B34F6B857583Q53553608-6F7927DB-F138-45D6-BC74-0C0450921B65Q53672229-59F5338C-CF52-4C69-920B-3AFABED3FC36
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Radiological assessment in psoriatic arthritis.
@en
Radiological assessment in psoriatic arthritis.
@nl
type
label
Radiological assessment in psoriatic arthritis.
@en
Radiological assessment in psoriatic arthritis.
@nl
prefLabel
Radiological assessment in psoriatic arthritis.
@en
Radiological assessment in psoriatic arthritis.
@nl
P2093
P356
P1476
Radiological assessment in psoriatic arthritis.
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/37.7.760
P577
1998-07-01T00:00:00Z